empagliflozin glp-1 Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study Two target trial emulation studies

But what does the research say about the presumed anti-aging supplement

I know Id rather deal with the minor inconveniences of current self-tanners for my insecurities than the risk of skin cancer.

Potential Blockbuster Drugs to be Approved in 2022, Image source: Reference [1] Blockbuster Drugs To Be Approved in 2022 Donanemab (Lilly) In 2021, the launch of the Alzheimer's disease therapy Aduhelm (aducanumab) was one of the biggest concerns in the industry and the beginning of a new wave of Alzheimer's disease R&D

Designed synthetic analogs of the helical peptide temporinLa with improved antitumor efficacies via charge modification and incorporation of the integrin v3 homing domain

Several working groups established different measures to characterize sarcopenia (hand grip, gate speed, standing from sitting position, etc.)

A phorbol ester-nonproliferative variant of swiss 3T3 cells is deficient in Na K CI ++ - cotransport activity